Sarasin & Partners LLP Medtronic PLC Transaction History

Sarasin & Partners LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 19, 2021	SELL	$100.57 - $117.14 $163 Million - $190 Million	-1,621,724 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$90.13 - $108.78 $25.1 Million - $30.3 Million	278,409 Added 20.73%	1,621,724 $169 Million
Q2 2020 Jul 17, 2020	BUY	$84.11 - $103.33 $70.2 Million - $86.2 Million	834,189 Added 163.85%	1,343,315 $123 Million
Q1 2020 Apr 30, 2020	BUY	$72.92 - $121.3 $28.8 Million - $48 Million	395,473 Added 347.97%	509,126 $45.9 Million
Q3 2019 Nov 08, 2019	BUY	$98.02 - $111.18 $1.87 Million - $2.12 Million	19,078 Added 20.17%	113,653 $12.3 Million
Q2 2019 Jul 18, 2019	BUY	$84.15 - $99.38 $4.63 Million - $5.47 Million	55,000 Added 138.98%	94,575 $9.21 Million
Q4 2018 Feb 12, 2019	SELL	$85.8 - $99.49 $548,433 - $635,940	-6,392 Reduced 13.91%	39,575 $3.6 Million
Q3 2018 Nov 09, 2018	BUY	$85.91 - $99.17 $3.95 Million - $4.56 Million	45,967 New	45,967 $4.52 Million

2,288

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $108B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Sarasin & Partners LLP with notifications on news.